Dry Eye Syndrome Market Region, Trends And Application | 2015 - 2019

Dry eye syndrome usually results in dryness of eyes due to deficient tear production or quick tear evaporation or deviation in tear uniformity. This syndrome is of two types: aqueous tear deficient dry eye and evaporative dry eye. In aqueous tear deficient dry eye, lacrimal glands do not produce enough tears, whereas meibomian gland dysfunction results in evaporative dry eye. Meibomian glands secrete lipids to slow tear evaporation and maintain tear stability. The symptoms include pain, redness, burning, and fatigue in the eye and decreased tolerance to continuous visual activity. Dry eye syndrome cannot be cured, but symptoms can be controlled. Teardrops and anti-inflammatory drugs are used in the treatment.

The report analysts forecast the global dry eye syndrome market to grow at a CAGR of 4.75% over the period 2014-2019.

Covered in this report:

• The report includes the present scenario and the growth prospects of the global dry eye syndrome market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of teardrops and anti-inflammatory drugs used in the treatment of dry eye syndrome. 

• The report, Global Dry Eye Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation.

To Read other reports of this category:
http://www.radiantinsights.com/catalog/pharmaceutical

The report includes a discussion of the key vendors operating in this market.

Key regions

•  Americas
•  APAC
•  EMEA

Key vendors

•  Alcon
•  Allergan
•  Otsuka Holdings
•  Santen Pharmaceuticals

Other prominent vendors

•  Acadia Pharmaceuticals                                                             
•  Aciex
•  Allostera Pharma
•  ArGentis
•  Auven Therapeutics (Celtic)
•  Bridge Pharma
•  Can-Fite
•  Cellzome

Key Market driver

•  Growing prevalence of dry eye syndrome
•  For a full, detailed list, view our report

Key Market challenge

•  Self-medication by patients
•  For a full, detailed list, view our report

Key market trend

•  Growing awareness about the syndrome
•  For a full, detailed list, view our report

Key questions answered in this report:

•  What will the market size be in 2019 and what will the growth rate be?
•  What are the key market trends?
•  What is driving this market?
•  What are the challenges to market growth?
•  Who are the key vendors in this market space?
•  What are the market opportunities and threats faced by the key vendors?
•  What are the strengths and weaknesses of the key vendors?